| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | M Yao | |
| Z Huang | |||
| A Sahgal | |||
| B S Teh | |||
| E L Chang | |||
| S S Lo | |||
| B J Slotman | |||
| N A Mayr | |||
| R D Timmerman | |||
| M Machtay | |||
| T E Schefter | |||
| P433 | issue | 6 | |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 378-387 | |
| P577 | publication date | 2013-02-01 | |
| P1433 | published in | Clinical Oncology | Q1812651 |
| P1476 | title | Serious complications associated with stereotactic ablative radiotherapy and strategies to mitigate the risk | |
| P478 | volume | 25 |
| Q60393607 | A feasibility dosimetric study on prostate cancer |
| Q26801050 | A review of stereotactic body radiotherapy - is volumetric modulated arc therapy the answer? |
| Q39360767 | Best of International Stereotactic Radiosurgery Society Congress 2013: stereotactic body radiation therapy. Part I: spinal tumors |
| Q26995851 | Complications from Stereotactic Body Radiotherapy for Lung Cancer |
| Q37341807 | Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma |
| Q89544503 | Exploratory analysis using machine learning to predict for chest wall pain in patients with stage I non-small-cell lung cancer treated with stereotactic body radiation therapy |
| Q48165161 | Guidelines for safe practice of stereotactic body (ablative) radiation therapy |
| Q47852547 | Improved effectiveness of stereotactic radiosurgery in large brain metastases by individualized isotoxic dose prescription: an in silico study |
| Q38609742 | Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription |
| Q37739358 | Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors |
| Q53589962 | Prophylactic dexamethasone effectively reduces the incidence of pain flare following spine stereotactic body radiotherapy (SBRT): a prospective observational study. |
| Q37238814 | Radioprotection of lung tissue by soy isoflavones |
| Q35450158 | Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial (99m)Tc-DMSA SPECT/CT. |
| Q53229237 | Soy Isoflavones Promote Radioprotection of Normal Lung Tissue by Inhibition of Radiation-Induced Activation of Macrophages and Neutrophils. |
| Q38230510 | Spine metastases: from radiotherapy, surgery, to radiosurgery |
| Q57811272 | Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity |
| Q37684116 | Stereotactic spine radiosurgery: Review of safety and efficacy with respect to dose and fractionation. |
| Q38367507 | Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future? |
| Q38225135 | The tolerance of gastrointestinal organs to stereotactic body radiation therapy: what do we know so far? |
Search more.